P19.02 Care Coordination: The experience of a Brain Cancer Care Coordinator in Australia

Por Nixon, S., Morison, J.
Publicado no Neuro Oncol (2017)

Anaplastic lymphoma kinase inhibition in metastatic non-small cell lung cancer: clinical impact of alectinib

Por Muller, Ittai B, de Langen, Adrianus J, Giovannetti, Elisa, Peters, Godefridus J
Publicado no Onco Targets Ther (2017)

STEM-03. CONSUMPTION OF A HIGH-FAT DIET INHIBITS THE TUMOR SUPPRESSIVE ACTIVITY OF HYDROGEN SULFIDE, DRIVING CANCER STEM CELL ENRICHMENT AND DISEASE AGGRESSION IN GLIOBLASTOMA

Por Silver, Daniel, Roversi, Gustavo, Bithi, Nazmin, Troike, Katie, Neumann, Chase, Mark Brown, J, Hine, Christopher, Lathia, Justin
Publicado no Neuro Oncol (2019)

SEOM clinical guidelines for the treatment of advanced prostate cancer (2020)

Por González del Alba, A., Méndez-Vidal, M. J., Vazquez, S., Castro, E., Climent, M. A., Gallardo, E., Gonzalez-Billalabeitia, E., Lorente, D., Maroto, J. P., Arranz, J. A.
Publicado no Clin Transl Oncol (2021)

Targeting of the Cancer-Associated Fibroblast—T-Cell Axis in Solid Malignancies

Por Harryvan, Tom J., Verdegaal, Els M. E., Hardwick, James C. H., Hawinkels, Lukas J. A. C., van der Burg, Sjoerd H.
Publicado no J Clin Med (2019)

Nanoparticles for manipulation of the developmental Wnt, Hedgehog, and Notch signaling pathways in cancer

Por Valcourt, DM, Dang, MN, Wang, J, Day, ES
Publicado no Ann Biomed Eng (2019)

Genetic Systems to Investigate Regulation of Oncogenes and Tumour Suppressor Genes in Drosophila

Por Lee, Jue Er Amanda, Cranna, Nicola J., Chahal, Arjun S., Quinn, Leonie M.
Publicado em 2012

Mouse models in the era of large human tumour sequencing studies

Por de Ruiter, J. R., Wessels, L. F. A., Jonkers, J.
Publicado no Open Biol (2018)

The Immunogenicity of Colorectal Cancer in Relation to Tumor Development and Treatment

Por de Vries, Natasja L., Swets, Marloes, Vahrmeijer, Alexander L., Hokland, Marianne, Kuppen, Peter J. K.
Publicado no Int J Mol Sci (2016)

Estimating the optimal rate of adjuvant chemotherapy utilization for stage III colon cancer

Por Karim, Safiya, Booth, Christopher M., Brennan, Kelly, Peng, Yingwei, Siemens, D. Robert, Krzyzanowska, Monika K., Mackillop, William J.
Publicado no Cancer Med (2019)

Estimating the optimal perioperative chemotherapy utilization rate for muscle‐invasive bladder cancer

Por Karim, Safiya, Mackillop, William J., Brennan, Kelly, Peng, Yingwei, Siemens, D. Robert, Krzyzanowska, Monika K., Booth, Christopher M.
Publicado no Cancer Med (2019)

Adhesion in Mammary Development: Novel Roles for E-Cadherin in Individual and Collective Cell Migration

Por Shamir, Eliah R., Ewald, Andrew J.
Publicado no Curr Top Dev Biol (2015)

mTOR Inhibition Ablates Cisplatin-Resistant Salivary Gland Cancer Stem Cells

Por Nakano, T., Warner, K.A., Oklejas, A.E., Zhang, Z., Rodriguez-Ramirez, C., Shuman, A.G., Nör, J.E.
Publicado no J Dent Res (2020)

T-Cell Aging-Associated Phenotypes in Autoimmune Disease

Por Tuantuan V. Zhao, Yuki Sato, Jorg J. Goronzy, Jorg J. Goronzy, Cornelia M. Weyand, Cornelia M. Weyand
Publicado em 2022-04-01

Linking physical activity to breast cancer risk via the insulin/insulin-like growth factor signalling system, Part 2: The effect of insulin/insulin-like growth factor signalling on breast cancer risk

Por Drummond, Ann E., Swain, Christopher T.V., Milne, Roger L., English, Dallas R., Brown, Kristy A., Skinner, Tina L., Lay, Jannelle, van Roekel, Eline H., Moore, Melissa M., Gaunt, Tom R., Martin, Richard M., Lewis, Sarah J., Lynch, Brigid M.
Publicado no Cancer Epidemiol Biomarkers Prev (2022)

Influence of Drug Formulation on OATP1B-Mediated Transport of Paclitaxel

Por Nieuweboer, Annemieke J.M., Hu, Shuiying, Hagenbuch, Bruno, Moghaddam-Helmantel, Inge Ghobadi, Gibson, Alice A., de Bruijn, Peter, Mathijssen, Ron H. J., Sparreboom, Alex
Publicado em 2014

MON-362 Undiagnosed Non-classic Congenital Adrenal Hyperplasia as a Driving Force for Persistent Hyperandrogenemia in Prostate Cancer

Por Awosanya, Tiwa, Hamidi, Oksana, Courtney, Kevin
Publicado no J Endocr Soc (2019)

Customizing the Therapeutic Response of Signaling Networks to Promote Antitumor Responses by Drug Combinations

Por Goltsov, Alexey, Langdon, Simon P., Goltsov, Gregory, Harrison, David J., Bown, James
Publicado em 2014

Differential oestrogen receptor binding is associated with clinical outcome in breast cancer

Por Ross-Innes, Caryn S., Stark, Rory, Teschendorff, Andrew E., Holmes, Kelly A., Ali, H. Raza, Dunning, Mark J., Brown, Gordon D., Gojis, Ondrej, Ellis, Ian O., Green, Andrew R., Ali, Simak, Chin, Suet-Feung, Palmieri, Carlo, Caldas, Carlos, Carroll, Jason S.
Publicado em 2012

The ubiquitin proteasome system – Implications for cell cycle control and the targeted treatment of cancer

Por Bassermann, Florian, Eichner, Ruth, Pagano, Michele
Publicado em 2013